Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cugno

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Circulation|December 1, 1994
Activation of complement and kinin systems after thrombolytic therapy in patients with acute myocardial infarction. A comparison between streptokinase and recombinant tissue-type plasminogen activatorA Agostoni, M Gardinali, D Frangi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 14, 2005
Kallikrein-kinin system in inflammatory bowel diseases: Intestinal involvement and correlation with the degree of tissue inflammationM Devani, M Vecchi, S Ferrero, et al.
Allergy|September 13, 2011
Mast cells are critically involved in serum-mediated vascular leakage in chronic urticaria beyond high-affinity IgE receptor stimulationF Bossi, B Frossi, O Radillo, et al.
Minerva Anestesiologica|November 13, 2008
Effects of recombinant human activated protein C on the fibrinolytic system of patients undergoing conventional or tight glycemic controlF Polli, M Savioli, M Cugno, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 9, 2017
Involvement of the IgE-basophil system and mild complement activation in haemophilia B with anti-factor IX neutralizing antibodies and anaphylaxisM Cugno, M E Mancuso, A Tedeschi, et al.
Clinical and Experimental Immunology|June 7, 2014
Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet's syndromeA V Marzano, D Fanoni, E Antiga, et al.
The Journal of Rheumatology|May 1, 2001
Treatment of Raynaud's phenomenon with intravenous prostaglandin E1alpha-cyclodextrin improves endothelial cell injury in systemic sclerosisM Gardinali, M R Pozzi, M Bernareggi, et al.
The Journal of Rheumatology|November 28, 2000
Homocysteine concentration in primary and systemic sclerosis associated Raynaud's phenomenonB Marasini, S Casari, A Bestetti, et al.
ASAIO Transactions|October 1, 1991
Extracorporeal circulation in sheep with normal bleeding time using a surface heparinized circuitR Marcolin, M Cugno, A Pesenti, et al.
Minerva Anestesiologica|April 17, 2010
Time course of endogenous nitric oxide inhibitors in severe sepsis in humansG Iapichino, M Umbrello, M Albicini, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Circulation|December 1, 1994
Activation of complement and kinin systems after thrombolytic therapy in patients with acute myocardial infarction. A comparison between streptokinase and recombinant tissue-type plasminogen activatorA Agostoni, M Gardinali, D Frangi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 14, 2005
Kallikrein-kinin system in inflammatory bowel diseases: Intestinal involvement and correlation with the degree of tissue inflammationM Devani, M Vecchi, S Ferrero, et al.
Allergy|September 13, 2011
Mast cells are critically involved in serum-mediated vascular leakage in chronic urticaria beyond high-affinity IgE receptor stimulationF Bossi, B Frossi, O Radillo, et al.
Minerva Anestesiologica|November 13, 2008
Effects of recombinant human activated protein C on the fibrinolytic system of patients undergoing conventional or tight glycemic controlF Polli, M Savioli, M Cugno, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 9, 2017
Involvement of the IgE-basophil system and mild complement activation in haemophilia B with anti-factor IX neutralizing antibodies and anaphylaxisM Cugno, M E Mancuso, A Tedeschi, et al.
Clinical and Experimental Immunology|June 7, 2014
Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet's syndromeA V Marzano, D Fanoni, E Antiga, et al.
The Journal of Rheumatology|May 1, 2001
Treatment of Raynaud's phenomenon with intravenous prostaglandin E1alpha-cyclodextrin improves endothelial cell injury in systemic sclerosisM Gardinali, M R Pozzi, M Bernareggi, et al.
The Journal of Rheumatology|November 28, 2000
Homocysteine concentration in primary and systemic sclerosis associated Raynaud's phenomenonB Marasini, S Casari, A Bestetti, et al.
ASAIO Transactions|October 1, 1991
Extracorporeal circulation in sheep with normal bleeding time using a surface heparinized circuitR Marcolin, M Cugno, A Pesenti, et al.
Minerva Anestesiologica|April 17, 2010
Time course of endogenous nitric oxide inhibitors in severe sepsis in humansG Iapichino, M Umbrello, M Albicini, et al.
Pageof 11